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L-Arginine-Induced Regional Cerebral Blood Flow Increase is Abolished After Transient Focal Cerebral Ischemia in the Rat Bernd Sporer, K. Helge Martens, Uwe Koedel, and *Roman L. Haberl Ludwig-Maximilians-Universitat Munchen, Neurologische Klinik, Marchioninistr, 15, Munchen, and *Abteilung fur Neurologie und klinische Neurophysiologie, Stadtisches Krankenhaus Munchen-Harlaching, Sanatoriumsplatz 2, Munchen, Germany Summary: We investigated the L-arginine-induced. regional cerebral blood flow (rCBF) enhancement after different dura tions of transient focal cerebral ischemia in the rat to determine if L-arginine increases rCBF after transient focal cerebral isch emia. Focal ischemia (5 minutes and 20 minutes) followed by 90 minutes of reperfusion was induced in a normotensive rat suture-model. Regional cerebral blood flow in both hemi spheres was measured by laser-Doppler-flowmetry. Reactivity of rCBF to L-arginine (300 mg/kg) was measured 45 minutes after reperfusion, and hypercapnia 90 minutes after reperfusion. The effect of D-arginine and pretreatment with the nitric oxide (NO) synthpse inhibitor N"'-nitro-L-arginine (L-NA) (10 mg/kg) was examined in additional groups. Hypercapnia and L-arginine Nitric oxide (NO) and NO donors are thought to act neuroprotectively in early stages of cerebral ischemia by improving CBF in the border zones of ischemia. There fore, NO and NO donors may be of relevance for clinical stroke therapy. However, there have also been many re ports on the neurotoxic effects of NO in cerebral isch emia (Dawson et aI., 1993; Huang et aI. , 1994; ladecola et aI., 1994; Yoshida et aI., 1994; Dawson, 1995) .
L-arginine, the substrate for NO-generation, dilates pial arteries and increases regional cerebral blood flow (rCBF) under physiological conditions (Morikawa et aI., 1992b; Morikawa et aI., 1994) . A nitric oxide-induced rCBF increase in the ischemic region was reported to be attenuated, when the drugs were applied 20 minutes after onset of ischemia (Dalkara et aI., 1994; Zhang and Iadecola, 1994) . It is unclear if the reduced effect of increased rCBF in sham operated controls and on the nonisch emic hemispheres. D-arginine did not. Twenty-minute long ischemia significantly reduced the response to L-arginine (con trol side: 115 ± 5.9%; ischemic side: 107 ± 6.1 %, n = 7) and hypercapnia,5 minutes of ischemia did not. N'" -nitro-L-arginine pretreatment partly restored the L-arginine-induced rCBF in crease. Thus, rCBF increase caused by L-arginine in the reper fusion period was unaffected by 5 minutes of ischemia, but reduced by 20 minutes of ischemia. The restoration after pre treatment with L-NA may be caused by attenuated production of cytotoxic substances, e.g., NO and related compounds. Key Words: Cerebral blood flow-Cerebral ischemia-Nitric ox ide-Hypercapnia-Laser-Doppler flowmetry-Rat.
L-arginine in cerebral ischemia is simply caused by the hypoxic condition or if there is evidence for a dysfunc tion of vascular smooth muscle response to NO.
The formation of NO from L-arginine is limited by the amount of the substrate level and oxygen requirement (Matheis et aI., 1992) . Nitric oxide production measured by nitrite concentrations or by a porphyritic microsensor method showed an increase up to 20 or 25 minutes, re spectively, and a subsequent decrease to baseline 60 min utes after onset of focal cerebral ischemia (Kader et aI., 1993; Malinski et aI., 1993) . Nitric oxide increased at the beginning of the reperfusion period (Malinski et aI., 1993) .
The aim of our study was to determine the influence of transient focal cerebral ischemia on the L-arginine induced rCBF increase in an area of compromised blood flow (25 to 50%) which has the potential to recover (Dirnagl, 1993) , and to determine the dependency of the impairment of cerebrovascular reactivity on the duration of ischemia. The rCBF response to L-arginine was measured in the reperfusion period to exclude a lack of oxygen as the limiting factor of constitutive nitric oxide synthase activity. One additional group under went pretreatment with a high dose of the nitric oxide synthase (NOS)-inhibitor NW-nitro-L-arginine (L-NA) to study whether NO formation may contribute to the impairment of vascular responses in the reperfusion pe riod.
MATERIALS AND METHODS

Rat model of transient focal cerebral ischemia
Adult male Wi star rats, weighing 260 to 300 g, were anes thetized with thiopental (100 mg/kg intraperitoneally), trache otomized, and artificially ventilated with an animal ventilator (model 683, Harvard Apparatus, South Natick, MA, U.S.A.). A catheter was inserted into the right femoral artery to continu ously measure mean arterial blood pressure and analyze blood gases. The right femoral vein was cannulated to substitute fluid and to apply drugs. The rats were kept at a constant temperature of approximately 37.5°C using a rectal thermometer-controlled heating pad.
Transient focal cerebral ischemia was induced by a modified method of intraluminal vascular occlusion (Longa et aI., 1989) . Briefly, the left common carotid artery was ligated and cannu lated with a polyethylene tube. A 3-0 surgical nylon suture with its tip heated near a tlame was inserted through the tube approximately 11 mm from the internal carotid artery/exter nal carotid artery bifurcation toward the intracranial part of the internal carotid artery. After placement of the laser-Doppler probes the suture was advanced 17 to 19 mm from the inter nal carotid artery/external carotid artery bifurcation until the laser-Doppler flow decreased to ischemic levels. Reperfusion was initiated by pulling back the suture into the lumen of the common carotid artery and allowing recirculation via the circle of Willis. Animals were excluded if there was no ischemic laser-Doppler flow decrease, no sufficient reperfusion or a massive laser-Doppler flow decrease in the contralateral hemisphere after the final insertion of the suture, suggest ing hemorrhagic infarction. At the end of the experiment, the base of skull was inspected to exclude hemorrhagic infarc tion.
Measurement of regional cerebral blood flow
Regional cerebral blood flow was continuously and simul taneously measured by a two channel laser-Doppler flowmeter (model Perimed, Periflux 4001 Master, Hirfalla, Sweden) in both hemispheres. For placement of the laser-Doppler probes parts of the parietal bones were gently abraded to a transparent bone layer. The laser-Doppler tlow probe was placed over an area free of large cerebral vessels. The measurement area was 5-to 6-mm lateral to midline and 1-to 2-mm caudal to bregma in both hemispheres. Before ischemia was induced, baseline cortical blood flow was monitored until it remained stable for at least 20 minutes. Then CO2 reactivity was tested to prove the integrity of the vascular bed. Another baseline of 30 minutes followed. Regional cerebral blood flow was expressed as per centage of change related to a baseline of 100%. At the end of the experiment, CO2 reactivity was measured a second time. Hypercapnia was produced by mechanically ventilating with 10% COb 21 % O2, and the balance of N2. Arterial blood gases and pH was analyzed before and after 7 minutes of hypercap nia. CO2 reactivity was considered normal if there was an increase in rCBF of at least 2% per I mm Hg increase in Pc02 (Jones et aI., 1989) .
Materials and experimental groups
We used L-NA, L-arginine, and D-arginine (Sigma Chemi cals, Deisenhofen, Germany). N"'-nitro-L-arginine (10 mg/kg body weight), L-arginine (300 mg/kg body weight), and D arginine (300 mg/kg body weight) were dissolved in 0.9% sa line.
Five experimental groups were investigated. Three groups (3, 4, and 5) were subjected to 20 minutes and one group (2) to 5 minutes of transient focal cerebral ischemia. Group I com prised sham-operated controls.
Group I: sham-operated controls (n = 5), Group 2: 5 minutes of ischemia/90 minutes of reperfusion L-arginine (300 mg/kg intravenously/5 min) 45 minutes after reperfusion (n = 6).
Group 3: 20 minutes of ischemia/90 minutes of reperfusion L-arginine (300 mg/kg intravenously/5 min) 45 minutes after reperfusion (n = 7).
Group 4: 20 minutes of ischemia/90 minutes of reperfusion D-arginine (300 mg/kg intravenously/5 min) 45 minutes after reperfusion (n = 6).
Group 5: L-NA pretreatment (10 mg/kg intravenously/5 min) 20 minutes before ischemia -20 minutes of ischemia/90 min utes of reperfusion-L-arginine (300 mg/kg intravenously/5 min) 45 minutes after reperfusion (n = 6).
Small amounts of arterial blood were withdrawn to avoid an excessive mean arterial blood pressure increase above the up per limit of cerebral autoregulation (-150 mm Hg) (Dirnagl and Pulsinelli, 1990) after infusion of L-NA.
Statistical analyses were performed by one-way analysis of variance and Student-Newman-Keuls procedure to detect group differences. To detect changes over time within each group a paired (-test was performed. Differences between hemispheres within each group were compared using an unpaired t-test. Data are given as mean ± SD.
RESULTS
Physiological variables
Mean arterial blood pressure, Po2, Peo2, pH, and he matocrit levels were within normal ranges in all experi mental groups. In preliminary experiments the adminis tration of L-NA induced an excessive increase in mean arterial pressure up to or even above the upper limit of cerebral autoregulation. Therefore, we modulated mean arterial pressure increase by withdrawing blood. Never theless, mean arterial pressure values were significantly higher in L-NA-treated than in untreated animals (Ta ble 1).
L-Arginine effect in the reperfusion period L-Arginine significantly increased reBF in the non ischemic hemisphere in all groups (Fig. 1 ). In the isch emic hemisphere, the reBF response to L-arginine was significantly reduced after 20 minutes, but not after 5 minutes of ischemia. In contrast to L-arginine, the ste reoisomeric and normally inactive D-arginine had no ef fect on reBF in either ischemic or control hemispheres within 30 minutes of infusion.
Pretreatment with L-NA partly restored L-arginine induced reBF increase in the ischemic hemisphere, and Mean arterial blood pressure (MAP) in all groups. Group 1: sham operated controls (n = 5); group 2: 5 minutes of ischemia; L-arginine infusion (300 lng/kg intravenously/5 min) 45 minutes after reperfusion (n = 6); group 3: 20 minutes of ischemia; L-arginine infusion (300 mg/kg intravenously/5 min) 45 minutes after reperfusion (n = 7); group 4: 20 minutes of ischemia; D-arginine infusion (300 mg/kg in travenously/S min) 45 minutes after reperfusion (n = 6); group 5: 20 minutes ischemia; NW -nitro-L-arginine pretreatment (10 mg/kg intrave nously/S min) 20 minutes before ischemia; L-arginine infusion (300 mg/kg intravenously/S min) 45 minutes after reperfusion (n = 6).
* p < 0.05, compared with groups 1,3, and 4; t p < 0.05, compared with groups I, 2, 3, and 4 (one-way analysis of variance and Student-Newman-Keuls test). Data are mean ± SO.
enhanced rCBF response to L-arginine in the nonisch emic hemisphere. There was a significant difference in the rCBF change between the ischemic and the nonisch emic hemisphere (Fig. 1) .
N"'-nitro-L.,arginine attenuated hyperemia during early reperfusion, but had no effect on rCBF during ischemia and advanced reperfusion
Preischemic rCBF values were significantly decreased in both hemispheres 20 minutes after administration of L-NA (ischemic hemisphere: 91 ± 6%; control hemi sphere: 82 ± 9% of baseline). This effect reached a maxi mum in the control hemisphere 30 minutes after L-NA application (78 ± 9% of baseline), and was still detected until L-arginine was applied. On occlusion of the middle cerebral artery, rCBF decreased to 32 ± 7% in group 2, 32 ± 7% in group 3, and 25 ± 7% in group 4 of the preischemic level without significant differences be tween these groups. NW-nitro-L-arginine treatment had no effect on ischemic rCBF values (3 1 ± 8%; not signifi cant). On reperfusion, hyperperfusion developed (group 2: 180 ± 36%; groups 3 and 4: 25 1 ± 83%; not signifi cant), followed by mild hypoperfusion (rCBF at 45 min utes of reperfusion, group 2: 73 ± 6%; group 3 and 4: 88 ± 12%). N'" -nitro-L-arginine treatment significantly re duced hyperperfusion (146 ± 37%, P < 0.05 compared with groups 3 and 4; Fig. 2 ), but did not influence hy poperfusion (8 1 ± 8%).
Influence of transient focal cerebral ischemia on hypercapnic reactivity
At the beginning of the experiments, hypercapnic re activity was within normal ranges in both hemispheres in all groups investigated (data not shown). In the ischemic hemisphere, the rCBF response to hypercapnia was sig-J Cereb Blood Flow Metab, Vol. 17. No. 10. 1997 nificantly reduced after 20 minutes, but not after 5 min utes of ischemia ( Fig. 3 ; Table 2 ). Neither L-NA nor L-arginine nor D-arginine had a significant effect on the reduction of hypercapnic reactivity. In the nonischemic hemisphere no change of CO2 reactivity was observed, with the exception of group 5 (pretreatment with L-NA), in which CO2 reactivity was slightly reduced (1.78 ± 0.59%). 
3, and 5 using one-way analysis of variance and Student
Newman-Keuls test). (b) Twenty minutes, but not 5 minutes of ischemia significantly reduced rCBF response to L-arginine in the ischemic hemisphere (* P < 0.05, compared with groups 1, 2, and 5 using one-way analysis of variance and Student-Newman Keuls test). There was a significant difference between the isch emic and the nonischemic hemispheres in L-arginine-induced rCBF increase after 20 minutes of ischemia (P < 0.05, using unpaired Student's t-test). No significant difference was observed between rCBF values after administration of either L-arginine or o-arginine. NW-nitro-L-arginine pretreatment partly restored rCBF response to L-arginine in the ischemic hemisphere, although there was still a significant difference between the ischemic and the nonischemic hemispheres (P < 0.05, using unpaired Stu dent's t-test). Data are mean ± SD. LDF, laser-Doppler flow. 
DISCUSSION
The present study shows that 20 minutes (but not 5 minutes) of transient focal cerebral ischemia followed by 90 minutes of reperfusion diminishes the rCBF increase elicited by L-arginine or hypercapnia. Pretreatment with L-NA attenuated cerebral hyperperfusion in the early reperfusion period. In addition, L-NA partly restored rCBF increase after administration of L-arginine. How ever, L-NA did not prevent loss of the hypercapnic re activity of cerebral vessels.
The mode of action of exogenous L-arginine is still under discussion. The fact that endogenous L-arginine is present in amounts that far exceed the Km of NOS sug gests that administering L-arginine should not enhance the synthesis of NO. However, previous studies showed that either topical or systemic L-arginine administration may induce an increase in rCBF under physiologic and pathophysiologic conditions (Morikawa et aI., 1994) . The linkage of the L-arginine effect to the L-argininelNO pathway was generally shown by the ineffectiveness of D-arginine and/or by the blockade with NOS inhibitors. There are several possible explanations for the so-called "L-arginine paradox" (Forstermann et aI., 1994) . First, the "functional" Km in intact cells may be higher than that of the purified enzyme. Second, an endogenous in hibitor of NOS may cause an increased requirement of L-arginine (Faraci et aI., 1995; Vallance et aI., 1992) . Third, exogenous L-arginine induces NO release by an indirect mechanism. Arna1 et ai. reported that L-arginine was able to reverse the inhibitory effect of L-glutamine on receptor-mediated NO release (Arnal et aI., 1995) . Blood gas analysis during systemic hypercapnia (30 minutes before ischemia and 90 minutes after reperfu sion). Group I: sham-operated controls (n = 5); group 2: 5 minutes of ischemia; L-arginine infusion (300 mg/kg intravenously/5 min) 45 minutes after reperfusion (n = 6); group 3: 20 minutes of ischemia; L-arginine infusion (300 mg/kg intravenously/5 min) 45 minutes after reperfusion (n = 7); group 4: 20 minutes of ischemia; D-arginine infusion (300 mg/kg intravenously/5 min) 45 minutes after reperfusion (n = 6); group 5: 20 minutes ischemia; N"'-nitro-L-arginine pretreatment (10 mg/kg intravenously/5 min) 20 minutes before ischemia; L arginine infusion )300 mg/kg intravenously/5 min) 45 minutes after reperfusion (n = 6). Data are mean ± SO. In experimental stroke models, exogenous L-arginine was found to decrease infarction volume. This protective effect of L-arginine therapy is probably caused by an increase of rCBF in the ischemic penumbra (Morikawa et aI., 1992 a,b; Morikawa et aI., 1994) . Thus, L-arginine (30 or 300 mg/kg intravenously), when administered early after onset of ischemia (5 minutes), enhanced isch emic rCBF and reduced infarct volume after permanent middle cerebral artery occlusion in spontaneously hyper tensive rats and Sprague-Dawley rats (Morikawa et aI., 1992a; Morikawa et aI., 1994) . Dalkara et al. (1994) found a significantly greater rCBF increase after early rather than delayed L-arginine administration in a spon taneously hypertensive rat model of focal cerebral isch-emia. However, after photothrombotic occlusion of the middle cerebral artery, L-arginine did not enhance CBF and did not reduce infarction volume in spontaneously hypertensive rats after early or late application (Prado et a!., 1996) . The inconsistent findings may be explained by differences in the experimental models. Ischemia is com plicated by thrombosis in the photothrombotic stroke model. Tissue exposed to thrombosis combined with ischemia revealed considerably more severe changes than those exposed to mechanically induced ischemia (Dietrich et aI., 1989; Prado et aI., 1996) .
Thrombosis combined with ischemia may aggravate reperfusion injury, possibly by releasing of platelet derived substances (Dietrich et aI., 1988; Wester et aI., 1992; Prado et aI., 1996) . In the mechanically induced middle cerebral artery occlusion model, the beneficial effect of L-arginine therapy seems to depend on the time of drug administration after onset of cerebral ischemia. This suggests that a reduction in NO production within the ischemic endothelium or a decrease of the smooth muscle response to NO accounts for the loss of reaction after longer lasting ischemia (Dalkara et a!., 1994). Nitric oxide synthase activity and NO/nitrite concentration within ischemic tissue were measured in rat models of middle cerebral artery occlusion (Kader et aI., 1993; Ma linski et aI., 1993; Zhang et aI., 1994) . Initiation of isch emia caused NO/nitrite concentrations to increase for up to 20 minutes, to peak at 10 to 20 minutes and to de crease at 60 minutes (Kader et aI., 1993; Malinski et aI., 1993) . Similarly, NOS activity increased approximately 10-fold from baseline levels 10 minutes after occlusion but decreased by 60 minutes after initiation of ischemia (Kader et a!., 1993) . Reperfusion after 2 hours of isch emia stimulated an increase in NO concentrations to above baseline levels for at least 1 hour (Malinski et aI., 1993) . In our study, L-NA pretreatment attenuated post ischemic hyperemia. In an earlier study, inhibition of NOS with L-NAME decreased early postischemic hyper emia after global cerebral ischemia in piglets (Greenberg et aI., 1995) . These findings suggest the integrity of NO production and the vascular smooth muscle response to NO during early reperfusion after short-term ischemia.
Because NO increase during reperfusion (Malinski et aI., 1993) indicates the integrity of NO synthesis, the inefficacy of L-arginine therapy may be caused by a re duction of the vascular smooth muscle response to NO. The microvascular bed may be damaged by the release of cytotoxic substances, e.g., NO and reactive oxygen spe cies. Similar to NO, superoxide anion is generated during reperfusion (Nelson et aI., 1992; Schreiber et aI., 1995) . The simultaneous production of NO and superoxide may cause formation of cytotoxic peroxynitrite anion (Beck man, 1990; Beckman et aI., 1990) , which exerts a variety of cytopathic effects, including initiation of membrane lipid peroxidation (Rubbo et aI., 1994) and inhibition of mitochondrial electron transport (Radi et aI., 1994) . The incomplete restoration of the L-arginine/NO-induced rCBF increase by L-NA treatment may be caused by an incomplete reduction in the levels of these cytotoxic sub stances.
Whereas L-arginine reactivity was partly restored after L-NA pretreatment, hypercapnic vasodilation remained abolished. Similar to the present study, earlier investiga tions showed·a blunted response of CBF to systemic hypercapnia in the core and adjacent areas of ischemia (Jones et aI., 1989) . The reason for the differential effect of L-NA pretreatment on the response to L-arginine and hypercapnia is unclear. Although previous studies sug gest that NO may be a mediator of hypercapnic dilation in the brain (ladecola and Zhang, 1994; Wang et aI. , 1994) , there are other mechanisms involved in CBF regulation during hypercapnia (Wang et aI., 1994) . In addition, different isoforms of the NOS may be involved, i.e. the endothelial NOS in L-arginine induced vasodila tion and the neuronal NOS in hypercapnia (Dawson, 1994; Iadecola et aI., 1994; Wang et aI., 1995) . The difference in the restoration of vascular responsiveness after reperfusion by L-NA supports the hypothesis that there is a selective vulnerability of vessel wall reactivity after ischemia,frather than a global loss of cell vascular response.
